Search results

An Age-Related Exponential Decline in the Risk of Multiple Islet Autoantibody Seroconversion During Childhood An Age-Related Exponential Decline in theRiskofMultiple Islet Autoantibody Seroconversion During Childhood https://doi.org/10.2337/dc20-2122 OBJECTIVE Islet autoimmunity develops before clinical type 1 diabetes and includes multiple and single autoantibody phenotypes. The objective was to

https://www.teddy.lu.se/sites/teddy.lu.se/files/2021-11/127_MP237_Bonifacio_Diab%20Care_2021.pdf - 2026-07-11

Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity Jill M. Norris,1 Hye-Seung Lee,2 Brittni Frederiksen,1 Iris Erlund,3 Ulla Uusitalo,2 Jimin Yang,2 Åke Lernmark,4 Olli Simell,5 Jorma Toppari,5,6 Marian Rewers,7 Anette-G. Ziegler,8 Jin-Xiong She,9 Suna Onengut-Gumuscu,10 Wei-Min Chen,10 Stephen S. Rich,10

https://www.teddy.lu.se/sites/teddy.lu.se/files/2021-11/82%2001252019_679_082_MP106a_Norris_Diabetes_2017.pdf - 2026-07-11

1 Utbildningsplan 1. IDENTIFIKATION • Programmets namn och inriktning: musikerutbildning, cembalo • Omfattning i högskolepoäng: 180 • Nivå: G. • Programkod: KGMUS. Inriktning: CEMB • Utbildningsplanen är beslutad i Konstnärliga fakultetsstyrelsen den 18 september 2008. Utbild­ ningsplanen träder i kraft den 1 juli 2009. 2. PROGRAMBESKRIVNING Musikerutbildning, cembalo, syftar till att utbilda musi

https://www.mhm.lu.se/sites/mhm.lu.se/files/kgmus_cemb_sve.pdf - 2026-07-11

Background: Guidelines discourage prediction of neurological outcome in comatose patients within the first 72 h after cardiac arrest. Increasing evidence suggests that patients with the most severe brain injury and those with no or minimal brain injury may be identified before 72 h using novel methods. We present a protocol for the EARLY-NEURO study, which aims to evaluate whether good and poor ou

There is an urgent need to start generating energy within cities in order to pave the way for a more sustainable and resilient society. Renewable energy by means of active solar energy systems (solar thermal, ST and/or photovoltaics, PV) can be generated using roofs and facades of buildings. In this study, the annual solar energy potential of typical Swedish city blocks was analysed in order to de

OBJECTIVE To evaluate the pharmacokinetics, tolerability and effect on endocrinology of bicalutamide given as once-daily monotherapy at doses of > 150 mg to patients with locally advanced (MO) or metastatic (M1) prostate cancer, with efficacy as a secondary endpoint. PATIENTS AND METHODS Patients were initially enrolled to receive bicalutamide 300 mg in a non-randomized phase, after which further

Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We p

Frågor kring tillit i det digitala, tycks det, ställs oftare och oftare: Hur ska vi hantera integritets- och övervakningsfrågor? Hur ska vi hantera den mätbarhet som följer av vår digitaliserade tillvaro? Vad är det som avgör vilka tjänster vi litar på och vilka vi inte litar på, i vilken mån spelar den tekniska säkerheten en roll? Liknande frågor kan ställas om vilka kunskapsinstitutioner vi lita

Background: Pulse wave velocity (PWV) is a biomarker for arterial stiffness, clinically assessed by applanation tonometry (AT). Increased use of phase-contrast cardiac magnetic resonance (CMR) imaging allows for PWV assessment with minor routine protocol additions. The aims were to investigate the acquired temporal resolution needed for accurate and precise measurements of CMR-PWV, and develop a t

This paper focuses on an emerging manufacturing technology called Additive Manufacturing (AM) and its potential to become a more efficient and cleaner manufacturing alternative. This work is built around selected case companies, where the benefit of AM compared to other more traditional technologies is studied through the comparison of resource consumption. The resource consumption is defined as r

Objective:: Our aim was to explore the presence of symptoms, symptom relief, and other key aspects of palliative care during the final week of life among older people residing in nursing homes. Method:: Our study employed data from the Swedish Palliative Care Register on all registered individuals aged 60 and older who had died in nursing homes during the years 2011 and 2012. Variables pertaining

We present a vertical nanowire InAs/GaAsSb/GaSb TFET with a highly scaled InAs diameter (20 nm). The device exhibits a minimum subthreshold swing of 48 mV/dec. for Vds = 0.1-0.5 V and achieves an Ion = 10.6 μA/μm for Ioff = 1 nA/μm at Vds = 0.3 V. The lowest subthreshold swing achieved is 44 mV/dec. at Vds= 0.05 V. Furthermore, a benchmarking is performed against state-of-the-art TFETs and MOSFETs

The number of patients affected by Alzheimer's disease among the population is currently growing, while the availability of resources for their assistance is decreasing. A solution for this problem is provided by the use of Ambient Assisted Living technologies, with the objectives to prolong the independent living of patients at home, to relieve assistance burden on caregivers, and to improve care

The European Commission has acknowledged the lack of cross-border utilization of losses. Companies operating internationally want to have a possibility to offset losses against taxable profits at the same time or as soon as possible after the losses incurred. If no such possibility is at hand, a cash-flow disadvantage arises and also, it leads to segmentation of the internal market. The asymmetrie

PURPOSE To compare the effect of therapy with anastrozole versus a combination of fulvestrant and anastrozole in women in first relapse of endocrine-responsive breast cancer. PATIENTS AND METHODS Postmenopausal women, or premenopausal women receiving a gonadotropin-releasing hormone agonist, with estrogen receptor- and/or progesterone receptor-positive disease at first relapse after primary trea